Acetylcholinesterase (AChE) plays an important role in the pathogenesis of neurodegenerative diseases by influencing the inflammatory response, apoptosis, oxidative stress and aggregation of pathological proteins. There is a search for new compounds that can prevent the occurrence of neurodegenerative diseases and slow down their course. The aim of this review is to present the role of AChE in the pathomechanism of neurodegenerative diseases. In addition, this review aims to reveal the benefits of using AChE inhibitors to treat these diseases. The selected new AChE inhibitors were also assessed in terms of their potential use in the described disease entities. Designing and searching for new drugs targeting AChE may in the future allow the discovery of therapies that will be effective in the treatment of neurodegenerative diseases.

Makaleyi görüntüle

Despite the improvements in life expectancy, neurodegenerative conditions have arguably become the most dreaded maladies of older people. The neuroprotective and anti-ageing potentials of essential oils (EOs) are widely evaluated around the globe. The objective of this review is to analyse the effectiveness of EOs as neuroprotective remedies among the four common age-related neurodegenerative diseases. The literature was extracted from three databases (PubMed, Web of Science and Google Scholar) between the years of 2010 to 2020 using the medical subject heading (MeSH) terms "essential oil", crossed with "Alzheimer's disease (AD)", "Huntington's disease (HD)", "Parkinson's disease (PD)" or "amyotrophic lateral sclerosis (ALS)". Eighty three percent (83%) of the studies were focused on AD, while another 12% focused on PD. No classifiable study was recorded on HD or ALS. EO from Salvia officinalis has been recorded as one of the most effective acetylcholinesterase and butyrylcholinesterase inhibitors. However, only Cinnamomum sp. has been assessed for its effectiveness in both AD and PD. Our review provided useful evidence on EOs as potential neuroprotective remedies for age-related neurodegenerative diseases.

Makaleyi görüntüle

Non-communicable diseases (NCDs) such as cancer, diabetes, and chronic respiratory and cardiovascular diseases continue to be threatening and deadly to human kind. Resistance to and side effects of known drugs for treatment further increase the threat, while at the same time leaving scientists to search for alternative sources from nature, especially from plants. Pentacyclic triterpenoids (PT) from medicinal plants have been identified as one class of secondary metabolites that could play a critical role in the treatment and management of several NCDs. One of such PT is ursolic acid (UA, 3 β-hydroxy-urs-12-en-28-oic acid), which possesses important biological effects, including anti-inflammatory, anticancer, antidiabetic, antioxidant and antibacterial effects, but its bioavailability and solubility limits its clinical application. Mimusops caffra , Ilex paraguarieni, and Glechoma hederacea, have been reported as major sources of UA. The chemistry of UA has been studied extensively based on the literature, with modifications mostly having been made at positions C-3 (hydroxyl), C12-C13 (double bonds) and C-28 (carboxylic acid), leading to several UA derivatives (esters, amides, oxadiazole quinolone, etc.) with enhanced potency, bioavailability and water solubility. This article comprehensively reviews the information that has become available over the last decade with respect to the sources, chemistry, biological potency and clinical trials of UA and its derivatives as potential therapeutic agents, with a focus on addressing NCDs.

Makaleyi görüntüle

Ethnopharmacological relevance This study has identified not only the wild plants collected for medical purposes by local people of Malatya Province in the Eastern Anatolia Region, but also the uses and local names of these plants. It tried to provide a source for researchers studying in ethnobotany, pharmacology and chemistry by comparing the information obtained from traditionally used herbs with previous laboratory studies. Aim of the study In Turkey, use of plants for medical purposes has been a tradition. This study aims to identify wild plants collected for medical purposes by the local people of Malatya Province, located in the Eastern Anatolia Region of Turkey, and to establish the uses and local names of these plants. Materials and methods A field study had been carried out for a period of approximately 2 years (2010-2011). A questionnaire was administered to the local people, through face-to-face interviews. During this period, 330 vascular plant specimens were collected. Demographic characteristics of participants, names of the local plants, their utilized parts and preparation methods were investigated and recorded. The plant species were collected within the scope of the study; herbarium materials were prepared; and the specimens were entitled. In addition, the relative importance value of the species was determined and informant consensus factor (FIC) was calculated for the medicinal plants included in the study. Results In the area of research, 132 individuals who had knowledge about plants were interviewed. Mean age of the respondents was 44 years (in 35-73 years range). 108 plants were found to be used for medical purposes before in the literature analysis of the plants used in our study, while 15 plants were found to have no literature records. The most common families are: Asteraceae (21 plants), Lamiaceae (14 plants), and Rosaceae (12 plants). Local people were recorded to use the aerial parts, branches, flowers, fruits, latex, leaves, matured fruits, peduncle, resin, rhizomes, root bark, roots, seeds and style of the plants. Besides, it was observed that they dried and stored plants in unfavorable seasons in order to use them later. The medicinal uses of Heracleum antasiaticum Manden., Pimpinella olivieroides Boiss. & Hausskn., Scandix iberica Bieb., Taraxacum hybernum Stev., Tripleurospermum transcaucasicum (Manden.) Pobed., Cerastium chlorifolium Fisch. & Mey., Andrachne telephioides L., Euphorbia denticulata Lam., Astragalus cephalotes Banks. & Sol. var. brevicalyx Eig., Geranium ibericum Cav., Cyclotrichium nivenum (Boiss.) Manden. & Scheng., Salvia syriaca L., Papaver arenarium Bieb., Dactylis glomerata L., Polygonum arenarium Waldst. & Kit. that we found were used in our study area and recorded for the first time. No information could be obtained regarding the names of eight wild plants that are being used in Malatya. In Turkey, local plant names display differences especially due to ethnographic reasons. The plants used in Malatya are known by the same or different local names in various parts of Anatolia. Our research area also includes people with Kurdish and Zaza ethnic origins. The respondents of the questionnaire are Turkish citizens. Conclusion These plants are used in the treatment of many diseases. Comparison of the data obtained in this study from derived the plants growing in Malatya with the experimental data obtained in previous laboratory studies proved ethnobotanical usages to a great extent. Literature review indicated that curative plants that grow in Malatya are used in different parts of the world for the treatment of the same or similar diseases. These plants, used for the treatment of many varying diseases, are abundantly found in this region. Drying enabled local people to use medicinal plants in every seasons of the year. The plant flora of Malatya is threatened by such factors as grazing, expansion of new agricultural lands, and unsustainable picking of plants to generate income. Steps should be taken immediately to ensure the inclusion of relevant flora within conservation designations.

Makaleyi görüntüle

Since Salvia species (Lamiaceae) have been recorded to be used against memory loss in European folk medicine, we herein examined in vitro anticholinesterase and antioxidant activities of 56 extracts prepared with petroleum ether, chloroform, ethyl acetate and methanol obtained from 14 Salvia species (Salvia albimaculata Hedge and Hub, Salvia aucheri Bentham var. canescens Boiss and Heldr, Salvia candidissima Vahl. ssp. occidentalis, Salvia ceratophylla L., Salvia cryptantha Montbret and Bentham, Salvia cyanescens Boiss and Bal., Salvia frigida Boiss, Salvia forskahlei L., Salvia halophilaHedge, Salvia migrostegia Boiss and Bal., Salvia multicaulis Vahl., Salvia sclarea L., Salvia syriaca L., Salvia verticillata L. ssp. amasiaca) growing in Turkey. The antioxidant activities were assessed by both chemical and enzymatic methods against 1,1-diphenyl-2-picrylhydrazyl (DPPH) radical-scavenging and xanthine/xanthine oxidase (XO) system generated superoxide anion radical inhibition. Anticholinesterase effect of the extracts was tested against both acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) at concentrations of 0.2 and 1 mg/ml using a microplate-reader assay based on the Ellman method. Most of the extracts did not show any activity against AChE at 0.2 mg/ml, while the chloroform extracts had noticeable inhibition against BChE between 47.7% and 74.7%. The most active extracts at 1 mg/ml for AChE inhibition were observed to be petroleum ether extract of Salvia albimaculata (89.4%) and chloroform extract of Salvia cyanescens (80.2%), whereas ethyl acetate extracts of Salvia frigida and Salvia migrostegia, chloroform extracts of Salvia candidissima ssp. occidentalis and Salvia ceratophylla, as well as petroleum ether extract of Salvia cyanescens were found to inhibit potently BChE (92.2%, 89.6%, 91.1%, 91.3%, and 91.8%, respectively). Particularly, the ethyl acetate and methanol extracts were observed to be highly active against both DPPH and XO. Our data indicates that nonpolar extracts of Salvia species for anticholinesterase activity and the polar extracts for antioxidant activity are worth further phytochemical evaluation for identifying their active components.

Makaleyi görüntüle